Hematology Department, Puwan Campus

The Department of Hematology of the Second Hospital of Dalian Medical University comprises three campuses: Xinghai Campus, Diamond Bay Campus, and Puwan Campus. It has a total of 10 wards, 1 provincial-level key laboratory, and 1 municipal-level key laboratory. There are currently 235 beds, including 14 Class 100 transplant beds. The department is currently a doctoral and master’s degree-granting site in hematology, a standardized residency training base of the Ministry of Health, a clinical key specialty in hematology in Liaoning Province, the Liaoning Provincial Hematopoietic Stem Cell Transplantation Medical Center, the Key Laboratory of Clinical Translational Medical Research on Hematopoietic Stem Cell Transplantation in Liaoning Province, the Institute of Hematopoietic Stem Cell Transplantation of Dalian Medical University, the Diamond Bay Institute of Hematological Diseases, the Children’s Hematologic Oncology Center, the Dalian Key Laboratory of Hematological Diseases (Leukemia), and a hematopoietic stem cell transplantation and collection unit of the China Marrow Donor Program.

The Department of Hematology at Puwan Campus continues the fine traditions of the Department of Hematology of the Second Hospital of Dalian Medical University, maintains standardized medical care with the Departments of Hematology at Xinghai Campus and Diamond Bay Campus, and allows free referrals between the three campuses. The consulting experts are all key members of the departments at Xinghai Campus and Diamond Bay Campus of the Second Hospital of Dalian Medical University, undertaking important medical tasks in the northern region of Dalian. The department currently has 30 beds and is equipped with leading domestic medical equipment, such as sterile purification laminar-flow bed covers. The medical team currently consists of 5 physicians, including 2 doctoral degree holders and 3 master’s degree holders, and the nursing team consists of 16 members.

The scope of diagnosis and treatment of the Department of Hematology at Puwan Campus mainly includes various hematological diseases, including acute and chronic leukemia, lymphoma, myeloma, bone marrow failure diseases, hematological diseases in the elderly, platelet diseases, congenital genetic diseases, and post-transplant management. The department carries out such technologies as high-dose chemotherapy for acute leukemia, sequential autologous transplantation following high-dose chemotherapy for the treatment of lymphoma, and chimeric antigen receptor T-cell immunotherapy (CAR-T) for the treatment of relapsed and refractory hematological diseases. The department is proficient in advanced domestic technological concepts and techniques. Under the leadership of Director Yan Jinsong, a member of the Hematology Professional Committee of the Chinese Medical Association and Chairperson of the Hematology Professional Committee of the Liaoning Medical Association, it treats various difficult and complex hematological diseases, benefiting patients with hematological diseases in the northern region of Dalian.